ALLAM, J. P., N. NOVAK, C. FUCHS, S. ASEN, S. BERGE, T. APPEL, E. GEIGER, J. P.
KOCHAN u. T. BIEBER (2003):
Characterization of dendritic cells from human oral mucosa: a new Langerhans' cell type with high constitutive FcepsilonRI expression.
J. Allergy Clin. Immunol. 112, 141-148
ARDAVIN, C., L. WU, C. L. LI u. K. SHORTMAN (1993):
Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population.
Nature 362, 761-763
BAJTAY, Z., E. CSOMOR, N. SANDOR u. A. ERDEI (2006):
Expression and role of Fc- and complement-receptors on human dendritic cells.
Immunol Lett. 104, 46-52
BANCHEREAU, J., B. DUBOIS, J. FAYETTE, N. BURDIN, F. BRIERE, P. MIOSSEC, M.
C. RISSOAN, K. C. VAN u. C. CAUX (1995):
Functional CD40 antigen on B cells, dendritic cells and fibroblasts.
Adv. Exp. Med. Biol. 378, 79-83
BANCHEREAU, J. u. A. K. PALUCKA (2005):
Dendritic cells as therapeutic vaccines against cancer.
Nat. Rev. Immunol. 5, 296-306
BEDROSIAN, I., R. MICK, S. XU, H. NISENBAUM, M. FARIES, P. ZHANG, P. A.
COHEN, G. KOSKI u. B. J. CZERNIECKI (2003):
Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients.
J Clin. Oncol. 21, 3826-3835
BOGAERT, L., A. MARTENS, B. C. DE u. F. GASTHUYS (2005):
Detection of bovine papillomavirus DNA on the normal skin and in the habitual surroundings of horses with and without equine sarcoids.
Res. Vet. Sci. 79, 253-258
BOOG, C. J., J. BOES u. C. J. MELIEF (1988):
Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses.
Eur. J. Immunol. 18, 219-223
BOUSSIOTIS, V. A., G. J. FREEMAN, J. G. GRIBBEN, J. DALEY, G. GRAY u. L. M.
NADLER (1993):
Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.
Proc. Natl. Acad. Sci. U. S. A 90, 11059-11063
BRELOER, M., B. KRETSCHMER, K. LUTHJE, S. EHRLICH, U. RITTER, T. BICKERT, C. STEEG, S. FILLATREAU, K. HOEHLIG, V. LAMPROPOULOU u. B. FLEISCHER (2007):
CD83 is a regulator of murine B cell function in vivo.
Eur. J Immunol 37, 634-648 CAMPO, M. S. (1997):
Bovine papillomavirus and cancer.
Vet. J 154, 175-188
CAUX, C., S. IT-YAHIA, K. CHEMIN, B. O. DE, M. C. EU-NOSJEAN, B. HOMEY, C.
MASSACRIER, B. VANBERVLIET, A. ZLOTNIK u. A. VICARI (2000):
Dendritic cell biology and regulation of dendritic cell trafficking by chemokines.
Springer Semin. Immunopathol. 22, 345-369
CAUX, C., C. MASSACRIER, B. VANBERVLIET, B. DUBOIS, I. DURAND, M. CELLA, A. LANZAVECCHIA u. J. BANCHEREAU (1997):
CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis.
Blood 90, 1458-1470
CHAMBERS, G., V. A. ELLSMORE, P. M. O'BRIEN, S. W. REID, S. LOVE, M. S.
CAMPO u. L. NASIR (2003d):
Sequence variants of bovine papillomavirus E5 detected in equine sarcoids.
Virus Res. 96, 141-145
CHAMBERS, G., V. A. ELLSMORE, P. M. O'BRIEN, S. W. REID, S. LOVE, M. S.
CAMPO u. L. NASIR (2003b):
Association of bovine papillomavirus with the equine sarcoid.
J Gen. Virol. 84, 1055-1062
CHOMARAT, P., C. DANTIN, L. BENNETT, J. BANCHEREAU u. A. K. PALUCKA (2003):
TNF skews monocyte differentiation from macrophages to dendritic cells.
J Immunol 171, 2262-2269
COATES, P. T., B. L. COLVIN, A. RANGANATHAN, F. J. DUNCAN, Y. Y. LAN, W. J.
SHUFESKY, A. F. ZAHORCHAK, A. E. MORELLI u. A. W. THOMSON (2004):
CCR and CC chemokine expression in relation to Flt3 ligand-induced renal dendritic cell mobilization.
Kidney Int. 66, 1907-1917
CROWLEY, M., K. INABA, M. WITMER-PACK u. R. M. STEINMAN (1989):
The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus.
Cell Immunol 118, 108-125
CROWLEY, M. T., K. INABA, M. D. WITMER-PACK, S. GEZELTER u. R. M.
STEINMAN (1990):
Use of the fluorescence activated cell sorter to enrich dendritic cells from mouse spleen.
J Immunol Methods 133, 55-66 DAHME, E. u. E. WEISS (1999):
Grundriß der speziellen pathologischen Anatomie der Haustiere.
5. Aufl. Verlag Enke, Stuttgart, S. 543
DANIEL, P. T., C. SCHOLZ, F. ESSMANN, J. WESTERMANN, A. PEZZUTTO u. B.
DORKEN (1999):
CD95/Fas-triggered apoptosis of activated T lymphocytes is prevented by dendritic cells through a CD58-dependent mechanism.
Exp. Hematol. 27, 1402-1408
DAVOUST, J. u. J. BANCHEREAU (2000):
Naked antigen-presenting molecules on dendritic cells.
Nat. Cell Biol. 2, E46-E48
DE ALMEIDA, M. C., A. C. SILVA, A. BARRAL u. N. M. BARRAL (2000):
A simple method for human peripheral blood monocyte isolation.
Mem. Inst. Oswaldo Cruz 95, 221-223
DEL HOYO, G. M., P. MARTIN, H. H. VARGAS, S. RUIZ, C. F. ARIAS u. C. ARDAVIN (2002):
Characterization of a common precursor population for dendritic cells.
Nature 415, 1043-1047
DEL, P. A., M. LOCATI, K. OTERO, E. RIBOLDI, A. MANTOVANI, A. VECCHI u. S.
SOZZANI (2006):
Migration of dendritic cells across blood and lymphatic endothelial barriers.
Thromb. Haemost. 95, 22-28
DIETZ, O. u. B. HUSKAMP (1999):
Handbuch Pferdepraxis
2. Aufl. Verlag Enke, Stuttgart, S. 250 – 251
DOHMANN, K., B. WAGNER, D. W. HOROHOV u. W. LEIBOLD (2000):
Expression and characterisation of equine interleukin 2 and interleukin 4.
Vet. Immunol Immunopathol. 77, 243-256
DZIONEK, A., A. FUCHS, P. SCHMIDT, S. CREMER, M. ZYSK, S. MILTENYI, D. W.
BUCK u. J. SCHMITZ (2000):
BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood.
J Immunol 165, 6037-6046
ELKORD, E., P. E. WILLIAMS, H. KYNASTON u. A. W. ROWBOTTOM (2005):
Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells.
Immunology 114, 204-212
ESTES, D. M., A. HIRANO, V. T. HEUSSLER, D. A. DOBBELAERE u. W. C. BROWN (1995):
Expression and biological activities of bovine interleukin 4: effects of recombinant bovine interleukin 4 on T cell proliferation and B cell differentiation and proliferation in vitro.
Cell Immunol 163, 268-279
FEAU, S., V. FACCHINETTI, F. GRANUCCI, S. CITTERIO, D. JARROSSAY, S.
SERESINI, M. P. PROTTI, A. LANZAVECCHIA u. P. RICCIARDI-CASTAGNOLI (2005):
Dendritic cell-derived IL-2 production is regulated by IL-15 in humans and in mice.
Blood 105, 697-702
FELZMANN, T., M. BUCHBERGER, M. LEHNER, D. PRINTZ, R. KIRCHEIS, E.
WAGNER, H. GADNER u. W. HOLTER (2001):
Functional maturation of dendritic cells by exposure to CD40L transgenic tumor cells, fibroblasts or keratinocytes.
Cancer Lett. 168, 145-154
FELZMANN, T., V. WITT, D. WIMMER, G. RESSMANN, D. WAGNER, P. PAUL, K.
HUTTNER u. G. FRITSCH (2003):
Monocyte enrichment from leukapharesis products for the generation of DCs by plastic adherence, or by positive or negative selection.
Cytotherapy. 5, 391-398
FONG, L., D. BROCKSTEDT, C. BENIKE, L. WU u. E. G. ENGLEMAN (2001):
Dendritic cells injected via different routes induce immunity in cancer patients.
J Immunol 166, 4254-4259
FOSTER, B., D. D. METCALFE u. C. PRUSSIN (2003):
Human dendritic cell 1 and dendritic cell 2 subsets express FcepsilonRI: correlation with serum IgE and allergic asthma.
J. Allergy Clin. Immunol. 112, 1132-1138
FREEMAN, G. J., F. BORRIELLO, R. J. HODES, H. REISER, J. G. GRIBBEN, J. W. NG, J.
KIM, J. M. GOLDBERG, K. HATHCOCK, G. LASZLO u. . (1993):
Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production.
J Exp. Med. 178, 2185-2192
FRETZ, P. B. u. S. M. BARBER (1980):
Prospective analysis cryosurgery as the sole treatment for equine sarcoids.
Vet. Clin. North Am. Small Anim Pract. 10, 847-859
GERBER, H. (1989):
Sir Frederick Hobday memorial lecture. The genetic basis of some equine diseases.
Equine Vet. J. 21, 244-248
GOODRICH, L., H. GERBER, E. MARTI u. D. F. ANTCZAK (1998):
Equine sarcoids.
Vet. Clin. North Am. Equine Pract. 14, 607-23, vii GUTMANN, S. (2005):
Erste Schritte zum Nachweis antigen-spezifischer zellulärer Immunantworten gegen das E7-Protein des bovinen Papillomavirus Typ1 beim Pferd.
Tierärztliche Hochschule Hannover, Dissertation HAMMAN J. (2004):
Equines Sarkoid- eine therapeutische Herausforderung.
Prakt. Tierarzt 85, (7), S. 495 - 498
HAMMOND, S. A., D. HOROHOV u. R. C. MONTELARO (1999):
Functional characterization of equine dendritic cells propagated ex vivo using recombinant human GM-CSF and recombinant equine IL-4.
Vet. Immunol. Immunopathol. 71, 197-214 HART, D. N. u. J. W. FABRE (1981a):
Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain.
J Exp. Med. 154, 347-361
HART, D. N. u. J. W. FABRE (1981b):
Major histocompatibility complex antigens in rat kidney, ureter, and bladder. Localization with monoclonal antibodies and demonstration of Ia-positive dendritic cells.
Transplantation 31, 318-325
HED, J., G. HALLDEN, S. G. JOHANSSON u. P. LARSSON (1989):
Quantitative rather than qualitative differences between monocytes with respect to IgE Fc receptor expression as studied by flow cytofluorometry.
Int. Arch. Allergy Appl. Immunol. 88, 408-411 HEUFLER, C., F. KOCH u. G. SCHULER (1988):
Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells.
J. Exp. Med. 167, 700-705
HOCHREIN, H., M. O'KEEFFE u. H. WAGNER (2002):
Human and mouse plasmacytoid dendritic cells.
Hum. Immunol 63, 1103-1110
HOLLOWAY, J. A., S. T. HOLGATE u. A. E. SEMPER (2001):
Expression of the high-affinity IgE receptor on peripheral blood dendritic cells: differential binding of IgE in atopic asthma.
J. Allergy Clin. Immunol. 107, 1009-1018
HOLTL, L., R. RAMONER, C. ZELLE-RIESER, H. GANDER, T. PUTZ, C. PAPESH, W.
NUSSBAUMER, C. FALKENSAMMER, G. BARTSCH u. M. THURNHER (2005):
Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide.
Cancer Immunol Immunother. 54, 663-670
HOLTL, L., C. RIESER, C. PAPESH, R. RAMONER, M. HEROLD, H. KLOCKER, C.
RADMAYR, A. STENZL, G. BARTSCH u. M. THURNHER (1999):
Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells.
J Urol. 161, 777-782
HOLTL, L., C. ZELLE-RIESER, H. GANDER, C. PAPESH, R. RAMONER, G. BARTSCH, H. ROGATSCH, A. L. BARSOUM, J. H. COGGIN, JR. u. M. THURNHER (2002):
Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells.
Clin. Cancer Res. 8, 3369-3376
HUS, I., J. ROLINSKI, J. TABARKIEWICZ, K. WOJAS, A. BOJARSKA-JUNAK, J.
GREINER, K. GIANNOPOULOS, A. DMOSZYNSKA u. M. SCHMITT (2005):
Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia.
Leukemia 19, 1621-1627
INABA, K., M. INABA, N. ROMANI, H. AYA, M. DEGUCHI, S. IKEHARA, S.
MURAMATSU u. R. M. STEINMAN (1992):
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.
J Exp. Med. 176, 1693-1702
JANEWAY C. A., P. TRAVERS, M. WALPORT u. M. SHLOMCHIK (2005):
Immunobiology - the immune system in health and disease.
6. Aufl. Verlag Garland Science Publishing, New York, USA
JIANG, W., W. J. SWIGGARD, C. HEUFLER, M. PENG, A. MIRZA, R. M. STEINMAN u.
M. C. NUSSENZWEIG (1995):
The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing.
Nature 375, 151-155
JONULEIT, H., A. GIESECKE-TUETTENBERG, T. TUTING, B. THURNER-SCHULER, T. B. STUGE, L. PARAGNIK, A. KANDEMIR, P. P. LEE, G. SCHULER, J. KNOP u. A. H.
ENK (2001):
A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.
Int. J Cancer 93, 243-251
JONULEIT, H., J. KNOP u. A. H. ENK (1996):
Cytokines and their effects on maturation, differentiation and migration of dendritic cells.
Arch. Dermatol. Res. 289, 1-8
JONULEIT, H., U. KUHN, G. MULLER, K. STEINBRINK, L. PARAGNIK, E. SCHMITT, J. KNOP u. A. H. ENK (1997):
Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions.
Eur. J Immunol 27, 3135-3142
JONULEIT, H., E. SCHMITT, G. SCHULER, J. KNOP u. A. H. ENK (2000):
Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells.
J Exp. Med. 192, 1213-1222 JOYCE, J. R. (1975):
Cryosurgery for removal of equine sarcoids.
Vet. Med. Small Anim Clin. 70, 200-203 JOYCE, J. R. (1976):
Cryosurgical treatment of tumors of horses and cattle.
J Am. Vet. Med. Assoc. 168, 226-229
KATOH, N., S. KRAFT, J. H. WESSENDORF u. T. BIEBER (2000):
The high-affinity IgE receptor (FcepsilonRI) blocks apoptosis in normal human monocytes.
J. Clin. Invest 105, 183-190 KELLER, R. (2001):
Dendritic cells: their significance in health and disease.
Immunol Lett. 78, 113-122
KIERTSCHER, S. M. u. M. D. ROTH (1996):
Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4.
J. Leukoc. Biol. 59, 208-218
KIM, K. W., S. H. KIM, J. G. SHIN, G. S. KIM, Y. O. SON, S. W. PARK, B. H. KWON, D.
W. KIM, C. H. LEE, M. Y. SOL, M. H. JEONG, B. S. CHUNG u. C. D. KANG (2004):
Direct injection of immature dendritic cells into irradiated tumor induces efficient antitumor immunity.
Int. J. Cancer 109, 685-690
KINNUNEN, R. E., T. TALLBERG, H. STENBACK u. S. SARNA (1999):
Equine sarcoid tumour treated by autogenous tumour vaccine.
Anticancer Res. 19, 3367-3374
KLEIN, W. R., G. E. BRAS, W. MISDORP, P. A. STEERENBERG, W. H. DE JONG, R. H.
TIESJEMA, A. W. KERSJES u. E. J. RUITENBERG (1986):
Equine sarcoid: BCG immunotherapy compared to cryosurgery in a prospective randomised clinical trial.
Cancer Immunol Immunother. 21, 133-140
KNIGHT, S. C., R. HUNT, C. DORE u. P. B. MEDAWAR (1985):
Influence of dendritic cells on tumor growth.
Proc. Natl. Acad. Sci. U. S. A 82, 4495-4497 KNOTTENBELT, D. C. u. D. F. KELLY (2000):
The diagnosis and treatment of periorbital sarcoid in the horse: 445 cases from 1974 to 1999.
Vet. Ophthalmol. 3, 169-191
KOKHAEI, P., A. CHOUDHURY, R. MAHDIAN, J. LUNDIN, A. MOSHFEGH, A.
OSTERBORG u. H. MELLSTEDT (2004):
Apoptotic tumor cells are superior to tumor cell lysate, and tumor cell RNA in induction of autologous T cell response in B-CLL.
Leukemia 18, 1810-1815
KUMAR, R. K. u. R. PENNY (1982):
Escape of tumours from immunological destruction.
Pathology 14, 173-179 LANE, J. G. (1977):
The treatment of equine sarcoids by cryosurgery.
Equine Vet. J 9, 127-133
LAVACH, J. D., K. E. SULLINS, S. M. ROBERTS, G. A. SEVERIN, C. WHEELER u. D.
C. LUEKER (1985):
BCG treatment of periocular sarcoid.
Equine Vet. J 17, 445-448
LAXMANAN, S., S. W. ROBERTSON, E. WANG, J. S. LAU, D. M. BRISCOE u. D.
MUKHOPADHYAY (2005):
Vascular endothelial growth factor impairs the functional ability of dendritic cells through Id pathways.
Biochem. Biophys. Res. Commun. 334, 193-198
LAZARY, S., H. GERBER, P. A. GLATT u. R. STRAUB (1985):
Equine leucocyte antigens in sarcoid-affected horses.
Equine Vet. J 17, 283-286
LAZARY, S., E. MARTI, G. SZALAI, C. GAILLARD u. H. GERBER (1994):
Studies on the frequency and associations of equine leucocyte antigens in sarcoid and summer dermatitis.
Anim Genet. 25 Suppl 1, 75-80
LECHMANN, M., S. BERCHTOLD, J. HAUBER u. A. STEINKASSERER (2002):
CD83 on dendritic cells: more than just a marker for maturation.
Trends Immunol 23, 273-275
LECHMANN, M., D. J. KROOSHOOP, D. DUDZIAK, E. KREMMER, C. KUHNT, C. G.
FIGDOR, G. SCHULER u. A. STEINKASSERER (2001):
The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells.
J. Exp. Med. 194, 1813-1821
LEE, T. H., Y. H. CHO u. M. G. LEE (2006):
Larger numbers of immature dendritic cells augment an anti-tumor effect against established murine melanoma cells.
Biotechnol. Lett.
LINETTE, G. P., D. ZHANG, F. S. HODI, E. P. JONASCH, S. LONGERICH, C. P.
STOWELL, I. J. WEBB, H. DALEY, R. J. SOIFFER, A. M. CHEUNG, S. G. EAPEN, S. V.
FEE, K. M. RUBIN, A. J. SOBER u. F. G. HALUSKA (2005):
Immunization using autologous dendritic cells pulsed with the melanoma-associated antigen gp100-derived G280-9V peptide elicits CD8+ immunity.
Clin. Cancer Res. 11, 7692-7699
LIPSCOMB, M. F. u. B. J. MASTEN (2002):
Dendritic cells: immune regulators in health and disease.
Physiol Rev. 82, 97-130
LIU, Y., X. BI, S. XU u. J. XIANG (2005):
Tumor-infiltrating dendritic cell subsets of progressive or regressive tumors induce suppressive or protective immune responses.
Cancer Res. 65, 4955-4962
LIVINGSTONE, L. R., A. WHITE, J. SPROUSE, E. LIVANOS, T. JACKS u. T. D. TLSTY (1992):
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.
Cell 70, 923-935
LUNN, D. P., M. A. HOLMES, D. F. ANTCZAK, N. AGERWAL, J. BAKER, S. DALI-AHCENE, M. BLANCHARD-CHANNELL, K. M. BYRNE, K. CANNIZZO, W. DAVIS, M. J. HAMILTON, D. HANNANT, T. KONDO, J. H. KYDD, M. C. MONIER, P. F.
MOORE, T. O'NEIL, B. R. SCHRAM, A. SHEORAN, J. L. STOTT, T. SUGIURA u. K. E.
VAGNONI (1998):
Report of the Second Equine Leucocyte Antigen Workshop, Squaw valley, California, July 1995.
Vet. Immunol. Immunopathol. 62, 101-143
LUNN, D. P., M. A. HOLMES u. W. P. DUFFUS (1991):
Three monoclonal antibodies identifying antigens on all equine T lymphocytes, and two mutually exclusive T-lymphocyte subsets.
Immunology 74, 251-257
LUNN, D. P., M. A. HOLMES u. W. P. DUFFUS (1993):
Equine T-lymphocyte MHC II expression: variation with age and subset.
Vet. Immunol. Immunopathol. 35, 225-238
MACAGNO, A., M. GILLIET, F. SALLUSTO, A. LANZAVECCHIA, F. O. NESTLE u. M.
GROETTRUP (1999):
Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation.
Eur. J Immunol 29, 4037-4042
MAHNKE, K., J. KNOP u. A. H. ENK (2003):
Induction of tolerogenic DCs: 'you are what you eat'.
Trends Immunol 24, 646-651
MAILLIARD, R. B., A. WANKOWICZ-KALINSKA, Q. CAI, A. WESA, C. M. HILKENS, M. L. KAPSENBERG, J. M. KIRKWOOD, W. J. STORKUS u. P. KALINSKI (2004):
alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity.
Cancer Res. 64, 5934-5937
MARTENS, A., M. A. DE, J. DEMEULEMEESTER u. R. DUCATELLE (2000):
Histopathological characteristics of five clinical types of equine sarcoid.
Res. Vet. Sci. 69, 295-300
MARTI, E., S. LAZARY, D. F. ANTCZAK u. H. GERBER (1993):
Report of the first international workshop on equine sarcoid.
Equine Vet. J. 25, 397-407 MATTIL-FRITZ, S. (2002):
Chimäre Virus-ähnliche Partikel des Bovinen Papillomvirus Typ1: Herstellung,
Charakterisierung und Verwendung in einer klinischen Phase I-Studie zur Immuntherapie des equinen Sarkoids.
Veterinärmedizinische Fakultät Leipzig, Dissertation
MAUEL S. (2002):
Klonierung und Expression von eq.IFN , eq.GM-CSF und eq.IL-4 und deren Einfluß auf die monozytären Zellen des Pferdes.
Fachbereich Veterinärmedizin der Freien Universität Berlin, Dissertation MAUEL, S., F. STEINBACH u. H. LUDWIG (2006):
Monocyte-derived dendritic cells from horses differ from dendritic cells of humans and mice.
Immunology 117, 463-473 MEDZHITOV, R. (2001):
Toll-like receptors and innate immunity.
Nat. Rev. Immunol 1, 135-145
MENETRIER-CAUX, C., M. C. THOMACHOT, L. ALBERTI, G. MONTMAIN u. J. Y.
BLAY (2001):
IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells.
Cancer Res. 61, 3096-3104
MEREDITH, D., A. H. ELSER, B. WOLF, L. R. SOMA, W. J. DONAWICK u. S. LAZARY (1986):
Equine leukocyte antigens: relationships with sarcoid tumors and laminitis in two pure breeds.
Immunogenetics 23, 221-225
MESSINA, J. P. u. D. A. LAWRENCE (1992):
Effects of 2-mercaptoethanol and buthionine sulfoximine on cystine metabolism by and proliferation of mitogen-stimulated human and mouse lymphocytes.
Int. J Immunopharmacol. 14, 1221-1234
MOHAMADZADEH, M., F. BERARD, G. ESSERT, C. CHALOUNI, B. PULENDRAN, J.
DAVOUST, G. BRIDGES, A. K. PALUCKA u. J. BANCHEREAU (2001):
Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells.
J Exp. Med. 194, 1013-1020
MOHAMMED, H. O., W. C. REBHUN u. D. F. ANTCZAK (1992):
Factors associated with the risk of developing sarcoid tumours in horses.
Equine Vet. J 24, 165-168
MORSE, M. A., S. NAIR, M. FERNANDEZ-CASAL, Y. DENG, P. M. ST, R. WILLIAMS, A. HOBEIKA, P. MOSCA, T. CLAY, R. I. CUMMING, E. FISHER, P. CLAVIEN, A. D.
PROIA, D. NIEDZWIECKI, D. CARON u. H. K. LYERLY (2000):
Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer.
J Clin. Oncol. 18, 3883-3893
MURPHY, J. M., G. A. SEVERIN, J. D. LAVACH, D. I. HEPLER u. D. C. LUEKER (1979):
Immunotherapy in ocular equine sarcoid.
NASIR, L. u. S. W. REID (1999):
Bovine papillomaviral gene expression in equine sarcoid tumours.
Virus Res. 61, 171-175
NERSTING, J., M. SVENSON, V. ANDERSEN u. K. BENDTZEN (2003):
Maturation of human dendritic cells by monocyte-conditioned medium is dependent upon trace amounts of lipopolysaccharide inducing tumour necrosis factor alpha.
Immunol Lett. 89, 59-65
NESTLE, F. O., S. ALIJAGIC, M. GILLIET, Y. SUN, S. GRABBE, R. DUMMER, G.
BURG u. D. SCHADENDORF (1998):
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.
Nat. Med. 4, 328-332
NOVAK, N., T. BIEBER u. N. KATOH (2001):
Engagement of Fc epsilon RI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells.
J. Immunol. 167, 797-804
NOVAK, N., R. VALENTA, B. BOHLE, S. LAFFER, J. HABERSTOK, S. KRAFT u. T.
BIEBER (2004):
FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro.
J. Allergy Clin. Immunol. 113, 949-957
OBUNIKE, J. C., S. PAKA, S. PILLARISETTI u. I. J. GOLDBERG (1997):
Lipoprotein lipase can function as a monocyte adhesion protein.
Arterioscler. Thromb. Vasc. Biol. 17, 1414-1420 ORMEROD, M. G. (1990):
An introduction to fluorescence technology.
In: Flow Cytometry – A Practical Approach.
Herausg.: M. G. Ormerod
IRL Press at Oxford University Press, New York, 29 – 44 PECHOLD, K., T. POHL, D. KABELITZ (1994):
Rapid quantifikation of lymphocyte subsets in heterogenous cell populations by flow cytometry
Cytometry. 16, 152-159
POLTORAK, A., X. HE, I. SMIRNOVA, M. Y. LIU, H. C. VAN, X. DU, D. BIRDWELL, E.
ALEJOS, M. SILVA, C. GALANOS, M. FREUDENBERG, P. RICCIARDI-CASTAGNOLI, B. LAYTON u. B. BEUTLER (1998):
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.
Science 282, 2085-2088
PRABHU DAS, M. R., S. S. ZAMVIL, F. BORRIELLO, H. L. WEINER, A. H. SHARPE u.
V. K. KUCHROO (1995):
Reciprocal expression of co-stimulatory molecules, B7-1 and B7-2, on murine T cells following activation.
Eur. J Immunol 25, 207-211
PRUETT, S. B., N. OBIRI u. J. L. KIEL (1989):
Involvement and relative importance of at least two distinct mechanisms in the effects of 2-mercaptoethanol on murine lymphocytes in culture.
J Cell Physiol 141, 40-45
PULENDRAN, B., S. DILLON, C. JOSEPH, T. CURIEL, J. BANCHEREAU u. M.
MOHAMADZADEH (2004):
Dendritic cells generated in the presence of GM-CSF plus IL-15 prime potent CD8+ Tc1 responses in vivo.
Eur. J Immunol 34, 66-73 RADBRUCH, A. (1992):
Immunfluorescence: Basic considerations.
In: Flow Cytometry and Cell Sorting.
Herausg.: A. Radbruch
Verlag Springer, Heidelberg, 34 – 36
RAGLAND, W. L., G. H. KEOWN u. J. R. GORHAM (1966):
An epizootic of equine sarcoid.
Nature 210, 1399-1415
RATTA, M., A. CURTI, M. FOGLI, M. PANTUCCI, G. VISCOMI, P. TAZZARI, F.
FAGNONI, R. VESCOVINI, P. SANSONI, S. TURA u. R. M. LEMOLI (2000):
Efficient presentation of tumor idiotype to autologous T cells by CD83(+) dendritic cells derived from highly purified circulating CD14(+) monocytes in multiple myeloma patients.
Exp. Hematol. 28, 931-940
RE, F. u. J. L. STROMINGER (2001):
Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells.
J Biol. Chem. 276, 37692-37699
REDDY, A., M. SAPP, M. FELDMAN, M. SUBKLEWE u. N. BHARDWAJ (1997):
A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells.
Blood 90, 3640-3646
REIMANN, J., W. BOHM u. R. SCHIRMBECK (1994):
Alternative processing pathways for MHC class I-restricted epitope presentation to CD8+
cytotoxic T lymphocytes.
Biol. Chem. Hoppe Seyler 375, 731-736
RENKVIST, N., C. CASTELLI, P. F. ROBBINS u. G. PARMIANI (2001):
A listing of human tumor antigens recognized by T cells.
Cancer Immunol Immunother. 50, 3-15
RESCIGNO, M., F. GRANUCCI, S. CITTERIO, M. FOTI u. P. RICCIARDI-CASTAGNOLI (1999):
Coordinated events during bacteria-induced DC maturation.
Immunol Today 20, 200-203
ROBERT, C., R. C. FUHLBRIGGE, J. D. KIEFFER, S. AYEHUNIE, R. O. HYNES, G.
CHENG, S. GRABBE, U. H. VON ANDRIAN u. T. S. KUPPER (1999):
Interaction of dendritic cells with skin endothelium: A new perspective on immunosurveillance.
J Exp. Med. 189, 627-636
ROEHM, N. W., H. J. LEIBSON, A. ZLOTNIK, J. KAPPLER, P. MARRACK u. J. C.
CAMBIER (1984):
Interleukin-induced increase in Ia expression by normal mouse B cells.
J Exp. Med. 160, 679-694 ROHWER, J. (2004):
Untersuchungen zur Typ I Allergie des Pferdes: Phänotypische Charakterisierung equiner TypI Effektorzellen und ihre Antikörper vermittelte Modulation.
Tierärztliche Hochschule Hannover, Dissertation
ROMANI, N., D. REIDER, M. HEUER, S. EBNER, E. KAMPGEN, B. EIBL, D.
NIEDERWIESER u. G. SCHULER (1996):
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.
J. Immunol. Methods 196, 137-151
ROSENZWAJG, M., S. CAMUS, M. GUIGON u. J. C. GLUCKMAN (1998):
The influence of interleukin (IL)-4, IL-13, and Flt3 ligand on human dendritic cell differentiation from cord blood CD34+ progenitor cells.
Exp. Hematol. 26, 63-72
SALLUSTO, F., M. CELLA, C. DANIELI u. A. LANZAVECCHIA (1995):
Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment:
downregulation by cytokines and bacterial products.
J Exp. Med. 182, 389-400
SALLUSTO, F. u. A. LANZAVECCHIA (1994):
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
J Exp. Med. 179, 1109-1118
SANTINI, S. M., P. T. DI, C. LAPENTA, S. PARLATO, M. LOGOZZI u. F. BELARDELLI (2003):
A new type I IFN-mediated pathway for the rapid differentiation of monocytes into highly active dendritic cells.
Stem Cells 21, 357-362
SANTINI, S. M., C. LAPENTA u. F. BELARDELLI (2005):
Type I interferons as regulators of the differentiation/activation of human dendritic cells:
methods for the evaluation of IFN-induced effects.
Methods Mol. Med. 116, 167-181
SANTINI, S. M., C. LAPENTA, M. LOGOZZI, S. PARLATO, M. SPADA, P. T. DI u. F.
BELARDELLI (2000):
Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.
J Exp. Med. 191, 1777-1788
SATO, H., A. SHIIYA, M. KIMATA, K. MAEBARA, M. TAMBA, Y. SAKAKURA, N.
MAKINO, F. SUGIYAMA, K. YAGAMI, T. MORIGUCHI, S. TAKAHASHI u. S.
BANNAI (2005):
Redox imbalance in cystine/glutamate transporter-deficient mice.
J Biol. Chem. 280, 37423-37429
SCHNORRER, P., G. M. BEHRENS, N. S. WILSON, J. L. POOLEY, C. M. SMITH, D. EL-SUKKARI, G. DAVEY, F. KUPRESANIN, M. LI, E. MARASKOVSKY, G. T. BELZ, F. R.
CARBONE, K. SHORTMAN, W. R. HEATH u. J. A. VILLADANGOS (2006):
The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture.
Proc. Natl. Acad. Sci. U. S. A 103, 10729-10734
SCHOENBERGER, S. P., R. E. TOES, D. VAN, V, R. OFFRINGA u. C. J. MELIEF (1998):
T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.
Nature 393, 480-483
SCHUBERTH, H. - J., M. HADAM u. W. LEIBOLD (1991):
Differentiation and transplantation antigens on surface of mononuclear cells of cattle, horses and dogs.
Dtsch. Tierärztl. Prax. 10, 119 – 122
SCHULER, G. u. R. M. STEINMAN (1985):
Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro.
J Exp. Med. 161, 526-546 SHIBAKI, A. (1998):
Fc epsilon RI on dendritic cells: a receptor, which links IgE mediated allergic reaction and T cell mediated cellular response.
J. Dermatol. Sci. 20, 29-38
SHORTMAN, K. (2000):
Burnet oration: dendritic cells: multiple subtypes, multiple origins, multiple functions.
Immunol Cell Biol. 78, 161-165 SHORTMAN, K. u. C. CAUX (1997):
Dendritic cell development: multiple pathways to nature's adjuvants.
Stem Cells 15, 409-419
SHORTMAN, K. u. Y. J. LIU (2002):
Mouse and human dendritic cell subtypes.
Nat. Rev. Immunol 2, 151-161
SIEDEK, E., S. LITTLE, S. MAYALL, N. EDINGTON u. A. HAMBLIN (1997):
Isolation and characterisation of equine dendritic cells.
Isolation and characterisation of equine dendritic cells.